Pharmacologic Issues in Liver Disease - 22/06/16
Doi : 10.1016/j.ccc.2016.02.003
Jolie Gallagher, PharmD a, b, Annie N. Biesboer, PharmD, BCPS c, Alley J. Killian, PharmD, BCPS a, ⁎ 
a Department of Pharmaceutical Services, Emory University Hospital, 1364 Clifton Road, Northeast, Atlanta, GA 30322, USA
b Mercer University College of Pharmacy, Atlanta, GA
c Concordia University of Wisconsin School of Pharmacy, 12800 North Lake Shore Drive, Mequon, WI 53097, USA
∗Corresponding author.
Riassunto |
This article describes key concepts for drug dosing considerations in liver disease. Included in this article is a review of pharmacokinetic changes that are known to occur in patients with liver disease that can aide in drug dosing. Although limited, the currently available pharmacokinetic data for medications that are commonly used in the critical care setting are also included.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Pharmacology, Liver disease, Drug dosing, Pharmacokinetics, Critical illness
Mappa
| Disclosures: Authors have no disclosures. |
© 2016
Elsevier Inc. Tutti i diritti riservati.
Vol 32 - N° 3
P. 397-410 - luglio 2016 Ritorno al numero
Articolo precedente
- Hematological Issues in Liver Disease
- Michael G. Allison, Carl B. Shanholtz, Ashutosh Sachdeva
- Infections in Liver Disease
- Rahul S. Nanchal, Shahryar Ahmad
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?